Masatoshi Inagaki Selected Research

Trazodone (Trittico)

8/2023	A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements.
10/2020	Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masatoshi Inagaki Research Topics

Disease

12	Neoplasms (Cancer) 07/2023 - 11/2002
4	Schizophrenia (Dementia Praecox) 01/2020 - 01/2019
4	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2005
3	Delirium 08/2023 - 10/2020
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 08/2013
3	Cognitive Dysfunction 01/2019 - 01/2007
3	Major Depressive Disorder (Major Depressive Disorders) 01/2018 - 04/2010
3	Fatigue 07/2015 - 02/2008
2	Neuroinflammatory Diseases 01/2020 - 07/2019
2	Hyperbilirubinemia 01/2020 - 07/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 04/2007
2	Mood Disorders (Mood Disorder) 04/2010 - 11/2009
1	Body Weight (Weight, Body) 08/2023
1	Periodontitis 08/2023
1	Psychomotor Agitation (Akathisia) 07/2023
1	Brain Diseases (Brain Disorder) 11/2022
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 11/2022
1	Neonatal Hyperbilirubinemia 01/2022
1	Kernicterus 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Primary Hyperparathyroidism 03/2021
1	Hypercalcemia (Milk Alkali Syndrome) 03/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Treatment-Resistant Depressive Disorder 08/2016
1	Anxiety Disorders (Anxiety Disorder) 10/2015
1	Neoplasm Metastasis (Metastasis) 07/2015
1	Anemia 07/2015
1	Amnesia (Dissociative Amnesia) 01/2013
1	Lung Neoplasms (Lung Cancer) 10/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2011
1	Death (Near-Death Experience) 03/2007
1	Cushing Syndrome 07/2002

Drug/Important Bio-Agent (IBA)

6	Antidepressive Agents (Antidepressants)IBA 09/2019 - 04/2007
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2008
4	suvorexantIBA 01/2021 - 10/2020
3	Riluzole FDA LinkGeneric 10/2015 - 01/2011
2	Antipsychotic Agents (Antipsychotics)IBA 08/2023 - 01/2019
2	Trazodone (Trittico)FDA LinkGeneric 08/2023 - 10/2020
2	dimemorfan (AT 17)IBA 01/2022 - 01/2019
2	CytokinesIBA 08/2013 - 02/2008
1	LipopolysaccharidesIBA 08/2023
1	Mirtazapine (Rexer)FDA LinkGeneric 07/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	KetanserinIBA 01/2022
1	BilirubinIBA 01/2022
1	Parathyroid Hormone (Parathormone)IBA 03/2021
1	ramelteon (Rozerem)FDA Link 01/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	SmokeIBA 11/2019
1	ParvalbuminsIBA 07/2019
1	C-Reactive ProteinIBA 07/2015
1	Carcinoembryonic AntigenIBA 07/2015
1	InterleukinsIBA 06/2014
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2011
1	LithiumIBA 11/2009
1	SteroidsIBA 02/2008
1	ImmunosorbentsIBA 02/2008
1	EnzymesIBA 02/2008
1	Glucose (Dextrose)FDA LinkGeneric 04/2007
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 12/2002
1	CalciumIBA 12/2002
1	Biomarkers (Surrogate Marker)IBA 12/2002
1	Indicators and Reagents (Reagents)IBA 11/2002
1	Metyrapone FDA Link 07/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2007
3	Radiotherapy 01/2019 - 05/2005
2	Palliative Care (Palliative Therapy) 07/2023 - 08/2013
2	Drug Therapy (Chemotherapy) 09/2019 - 01/2018
2	Adjuvant Chemotherapy 01/2007 - 07/2005
1	Intraperitoneal Injections 08/2023
1	Critical Care (Surgical Intensive Care) 10/2020
1	Oral Hygiene (Dental Hygiene) 07/2019
1	Aftercare (After-Treatment) 01/2019
1	Transcranial Magnetic Stimulation 08/2016